NorthWest Biotherapeutics Inc (NWBO)

[Fireman02360]

Acquired: The facts surrounding NW Bio suggest so. No new employees and a aging Management Team at or over retirement age.

Compare this to AVXL, who even during Phase 2 trials were adding people.....many have been commercialization experts experienced in brining drugs to market. Its a very sophisticated process (BLA /NDA) and NW hasn't added anyone experienced in this realm. This tells me everything I need to know about the direction Linda Powers plans on going. I am fine with it....sell to Merck or highest bidder who has the infrastructure and experience to get this to the masses, and very quickly......Logistics matter too. The drug also needs to be marketed, NW doesn't have a marketing team. Now, had NW been adding positions the whole time, I would change my thinking on this issue. But they haven't and have had the data for quite some time now. You tell me what's the better option for patients and shareholders? JV or Acquire?

-Fireman